NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.3970
0.00 (0.00%)
Nov 12, 2026, 10:10 AM CET
NFL Biosciences Revenue
NFL Biosciences had revenue of 3.12K EUR in the half year ending June 30, 2026, with 7,687.50% growth. This brings the company's total for the last twelve months to 3.15K, up 1,817.68% year-over-year. In the year 2025, NFL Biosciences had annual revenue of 188.00 with 308.70% growth. That makes NFL Biosciences the 47,523rd largest company in the world by revenue and 630th in France.
Revenue (ttm)
3.15K
Revenue Growth
+1,817.68%
P/S Ratio
1,599.64
Revenue / Employee
786.25
Employees
4
Market Cap
5.03M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 188.00 | 142.00 | 308.70% |
| Dec 31, 2024 | 46.00 | -199.97K | -99.98% |
| Dec 31, 2023 | 200.01K | 199.99K | 909,040.91% |
| Dec 31, 2022 | 22.00 | -17.00 | -43.59% |
| Dec 31, 2021 | 39.00 | 36.00 | 1,200.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 24.58M |
| Advicenne | 10.74M |
| Poxel | 7.66M |
| Aelis Farma | 2.19M |
| Oncodesign Precision Medicine Société anonyme | 1.80M |
| Plant Advanced Technologies | 1.56M |
| Aton | 602.00K |
| Quantum Genomics Société Anonyme | 10.00 |